Sun Pharma Gets USFDA Approval for Migraine Injection

Drug firm Sun Pharma today said it has received the U.S. health regulator’s approval for the launch of its generic Sumatriptan Succinate injections, used in the treatment of migraines and headaches, in the American market.
The Economic Times